Antibodies - Antibody patterns may predict inflammatory bowel disease years before diagnosis
View as a Web Page
News Medical
 
  Antibodies Antibodies logo  
  The latest antibodies news from News Medical  
 

Biologics Stability Screening Toolkit: Three Practical Workflows for Accelerating Formulation DevelopmentBiologics Stability Screening Toolkit: Three Practical Workflows for Accelerating Formulation Development

From early candidate selection to formulation optimisation, stability assessment is critical throughout biologics development. This practical toolkit brings together three workflows demonstrating how researchers can rapidly evaluate aggregation, colloidal stability and formulation performance, helping to streamline decision-making and reduce development risk across a range of biologic modalities.

Download the eBook
 
   Antibody patterns may predict inflammatory bowel disease years before diagnosisAntibody patterns may predict inflammatory bowel disease years before diagnosis
 
A large-scale study, presented today at UEG Week 2026, has identified distinct antibody patterns up to 10 years before the diagnosis of inflammatory bowel disease (IBD), potentially opening new avenues for earlier risk detection and providing insights into future disease course.
 
   Breast milk antibodies show promise against multiple respiratory virusesBreast milk antibodies show promise against multiple respiratory viruses
 
Yona Tugg and colleagues show that a polyclonal secretory immunoglobulin A preparation, purified from breast milk pooled from multiple donors, neutralized respiratory syncytial virus (RSV), human adenovirus type 5, and H1N1 and H3N2 influenza A viruses in laboratory assays.
 
 An approved Ebola antibody may miss its mark against Bundibugyo virus
 
An approved Ebola antibody may miss its mark against Bundibugyo virusResearchers analyzed 44 Bundibugyo virus genomes and modeled how approved and experimental Ebola antibodies might bind the virus’s glycoprotein. The models predicted disrupted binding for Ebanga, conserved targets for MBP134, and different binding behavior for the complete Inmazeb cocktail than for two of its antibodies alone; laboratory tests are needed to determine whether these findings translate into treatment benefit.
 
 
 MLC1 auto-antibodies identified as possible trigger for NMOSD-like diseases
 
MLC1 auto-antibodies identified as possible trigger for NMOSD-like diseasesNMOSD is an inflammatory autoimmune disorder that damages support and supply cells in the central nervous system, known as astrocytes.
 
 
 Dual-targeting antibody successfully tackles multiple tumor types in mice
 
Dual-targeting antibody successfully tackles multiple tumor types in miceA novel antibody therapy empowers the immune system's tumor-fighting capabilities in mice by targeting immune-suppressing T cells with greater precision than previous approaches, according to new work.
 
 
 Poorly validated research antibodies linked to millions of wasted samples
 
Poorly validated research antibodies linked to millions of wasted samplesA widespread failure to validate research antibodies before use is estimated to lead to the avoidable waste of millions of animal and human tissue samples worldwide, and an international expert panel has reached consensus on how to address the problem, according to two studies published October 6th in the open access journal PLOS Biology by Harvinder Virk of the University of Leicester, UK, and colleagues.
 
 
 New monoclonal antibody therapy significantly lowers patient triglyceride levels
 
New monoclonal antibody therapy significantly lowers patient triglyceride levelsA phase 2b clinical trial led by Mass General Brigham Heart and Vascular Institute researchers shows that a monoclonal antibody therapy called MAR001 can significantly reduce triglyceride levels within 12 weeks for patients with high triglyceride levels.
 
 
 New method detects lung antibodies through non-invasive exhaled breath
 
New method detects lung antibodies through non-invasive exhaled breathFor the first time, researchers have succesfully measured antibodies against specific respiratory viruses in exhaled air. This is shown in a new study involving, amongst others, the Karolinska Institutet, published in eBioMedicine.
 
 
 Antibody therapy teaches the immune system to control HIV
 
Antibody therapy teaches the immune system to control HIVThere is no cure for HIV. While scientists have made considerable progress in controlling the infection, patients still must take daily antiretroviral medication for the rest of their lives.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney

Copyright © 2000-2026